David Rodriguez is a Research Scientist in Translational Biology at Eli Lilly and Company. Previously, they worked as a Research Associate II at Fusion Pharmaceuticals, focusing on Targeted Alpha Therapeutic technology for cancer treatment. David also served as a Teaching Assistant at McMaster University and gained extensive educational qualifications, including a Master's Degree in Medical Clinical Sciences from McMaster University, a Bachelor of Science from Brock University, and an Advanced Diploma from Fleming College. In 2024, David will begin a role as Associate Research Scientist at POINT Biopharma.
This person is not in the org chart
This person is not in any teams
This person is not in any offices